Sustained benefit for parental tobacco control program
Jonathan P. Winickoff, M.D., M.P.H., from the Massachusetts General Hospital for Children in Boston, and colleagues conducted a cluster randomized trial of 20 pediatric practices in 16 states. Practices were randomized to the intervention, which provided training so that they could give evidence-based assistance for parents who smoke. Provision of meaningful tobacco control assistance was assessed at a 12-month follow-up telephone survey with parents.
The researchers found that during the 12-month implementation period, the intervention group had significantly higher practice rates of providing meaningful tobacco control assistance (55 versus 19 percent); discussing various strategies to quit smoking (25 versus 10 percent); discussing cessation medication (41 versus 11 percent); and recommending use of quitline (37 versus 9 percent) compared with the control group (all P < 0.0001). The likelihood of cotinine-confirmed quitting correlated with receipt of any assistance (adjusted odds ratio, 1.89; 95 percent confidence interval, 1.13 to 3.19). In intervention versus control practices, the adjusted odds ratio for cotinine-confirmed quitting was 1.07 (95 percent confidence interval, 0.64 to 1.78) after adjustment for demographic and behavioral factors.
"Maximizing parental quit rates will require more complete systems-level integration and adjunctive cessation strategies," the authors write.
One author disclosed financial ties to Pfizer and UpToDate.
Full Text (subscription or payment may be required)
Copyright © 2014 HealthDay. All rights reserved.